lifestyle.celebhomes.net
Home
Sample Page
Author:
AB Science
AB Science provides an update on its clinical development program.
April 16, 2026
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
February 10, 2026
AB Science reçoit un avis d’autorisation pour un brevet américain couvrant le masitinib dans le traitement du cancer de la prostate métastatique hormono-resistant
January 29, 2026